Xiaoyi xiaoyi Guo, Xu Liang, Hua Zhu. "Molecular imaging as a tool to predict patient outcomes in advanced HER2-low breast cancer on trastuzumab deruxtecan (T-DXd): The FHERAD trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1052